Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.32 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20960011 | 0.87 | POLRMT (0.39) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL19101894 | 0.78 | POLRMT (0.41) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL27438673 | 0.78 | POLRMT (0.41) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL19779072 | 0.75 | POLRMT (0.51) | POLRMTMAP4K4 | |
| SCHEMBL19779071 | 0.75 | POLRMT (0.40) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL19101798 | 0.75 | POLRMT (0.40) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL23844094 | 0.75 | POLRMT (0.42) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL16698694 | 0.75 | POLRMT (0.46) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL26229927 | 0.73 | POLRMT (0.41) | POLRMTMAP4K4STING1DOT1L | |
| SCHEMBL16708513 | 0.73 | POLRMT (0.39) | POLRMTMAP4K4DOT1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10377761-B2 | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections | GILEAD SCIENCES, INC. (US) | 2019-08-13 | — | — | US | disclosed |
| US-20190055253-A1 | PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | GILEAD SCIENCES, INC. | 2019-02-21 | — | — | US | disclosed |
| US-9701682-B2 | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections | GILEAD SCIENCES, INC. (US) | 2017-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10377761-B2 | Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections | SYNJ1, SARS1, SYNJ2 | POLRMT 306/4885MAP4K4 2212/4885STING1 1182/4885 |
| US-20190055253-A1 | PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | SYNJ1, SARS1, SYNJ2 | POLRMT 306/4885MAP4K4 2212/4885STING1 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.